Item

3. 
Legal Proceedings
Information regarding reportable legal proceedings is contained in Note 18 to the Consolidated Financial Statements and incorporated herein by reference. 
Item 4. 
Mine Safety Disclosures
Not applicable.
16 
Information about our Executive Officers 
The section below provides information regarding our executive officers as of September 10, 2025:
Name, Present Title & Business Experience
Age
Year First
Appointed
Executive
Officer
Carrie L. Anderson, Executive Vice President and Chief Financial Officer. Executive Vice President and Chief Financial Officer, Integra LifeSciences Holdings Corporation (2019-2023). 
56
2023
Mick J. Beekhuizen, President and Chief Executive Officer. We have employed Mr. Beekhuizen in an executive or managerial capacity for at least five years. 
49
2020
Charles A. Brawley, III, Executive Vice President, General Counsel and Corporate Secretary. We have employed Mr. Brawley in an executive or managerial capacity for at least five years.
60
2023
Risa Cretella, Executive Vice President and President, Meals & Beverages. Executive Vice President, General Manager of Rao’s, Sovos Brands, Inc. (2018-2024).
46
2025
Elizabeth M. Duggan, Executive Vice President and President, Snacks. We have employed Ms. Duggan in an executive or managerial capacity for at least five years.
45
2025
Diane Johnson May, Executive Vice President and Chief People and Culture Officer. Senior Vice President, People and Culture, Manpower Group (2020-2021). Executive Vice President, Chief Human Resources Officer, Brookdale Senior Living (2019-2020). 
66
2022
Janda K. Lukin, Executive Vice President and Chief Growth Officer. We have employed Ms. Lukin in an executive or managerial capacity for at least five years.
52
2025
Daniel L. Poland, Executive Vice President and Chief Enterprise Transformation Officer. Chief Operating Officer, KIND Snacks (2019-2021). 
62
2022
Anthony J. Sanzio, Executive Vice President and Chief Communications Officer. We have employed Mr. Sanzio in an executive or managerial capacity for at least five years.
57
2022
17 
PART II
Item 5
. Market for Registrant’s Capital Stock, Related Shareholder Matters and Issuer Purchases of Equity Securities 
Market for Registrant’s Capital Stock 
Our capital stock is traded on The Nasdaq Stock Market LLC under the symbol "CPB." On September 10, 2025, there were 13,902 holders of record of our capital stock. 
Return to Shareholders
*
 Performance Graph 
The information contained in this Return to Shareholders Performance Graph section shall not be deemed to be "soliciting material" or "filed" or incorporated by reference in future filings with the Securities and Exchange Commission (SEC), or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), except to the extent we specifically incorporate it by reference into a document filed under the Securities Exchange Act of 1933, as amended (the Securities Act), or the Exchange Act. 
The following graph compares the cumulative total shareholder return (TSR) on our stock with the cumulative total return of the Standard & Poor’s 500 Stock Index (the S&P 500) and the Standard & Poor’s Packaged Foods Index (the S&P Packaged Foods Group). The graph assumes that $100 was invested on July 31, 2020, in each of our stock, the S&P 500 and the S&P Packaged Foods Group, and that all dividends were reinvested. The total cumulative dollar returns shown on the graph represent the value that such investments would have had on August 3, 2025. 
* 
Stock appreciation plus dividend reinvestment. 
2020
2021
2022
2023
2024
2025
Campbell
100
91
106
102
107
77
S&P 500
100
136
130
147
177
205
S&P Packaged Foods Group
100
107
121
127
114
107
18 
Issuer Purchases of Equity Securities

Period
Total Number
of Shares
Purchased
(1)

Average
Price Paid
Per Share
(2)

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans or
Programs
(3)
Approximate
Dollar Value of
Shares that may yet
be Purchased
Under the Plans or
Programs
($ in Millions)
(3)
4/28/25 - 5/30/25
— 
$
— 
— 
$
501 
6/2/25 - 6/30/25
55,956 
$
33.44 
55,956 
$
499 
7/1/25 - 8/1/25
— 
$
— 
— 
$
499 
Total
55,956 
$
33.44 
55,956 
$
499 
____________________________________

(1)
Shares purchased are as of the trade date.
(2)
Average price paid per share is calculated on a settlement basis and excludes commission and excise tax. As of January 1, 2023, our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the Consolidated Statements of Equity.
(3)
In September 2021, the Board approved a strategic share repurchase program of up to $
500
 million (September 2021 program). The September 2021 program has no expiration date, but it may be suspended or discontinued at any time. Repurchases under the September 2021 program may be made in open-market or privately negotiated transactions. 
In September 2024, the Board authorized an anti-dilutive share repurchase program of up to $250 million (September 2024 program) to offset the impact of dilution from shares issued under our stock compensation programs. The September 2024 program has no expiration date, but it may be suspended or discontinued at any time. Repurchases under the September 2024 program may be made in open-market or privately negotiated transactions
. The September 2024 program replaced an anti-dilutive share repurchase program of up to $250 million that was approved by the Board in June 2021 and has been terminated.
Item 6. 
Reserved